UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

The Journal of pathology, 2008-08, Vol.215 (4), p.398-410

2008

Volltextzugriff (PDF)

Abstract P3-11-08: Sperm associated antigen 5 (SPAG5) predicts pathological complete response (pCR) and distant relapse risk to HER2 targeting agents and anthracycline based chemotherapy in HER2 positive (HER2+) breast cancer (BC)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-11-08

2019

Volltextzugriff (PDF)

Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?

Annals of the Royal College of Surgeons of England, 2022-05, Vol.104 (5), p.361-366

2022

Volltextzugriff (PDF)

High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

International journal of cancer, 2005-09, Vol.116 (3), p.340-350

2005

Volltextzugriff (PDF)

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

Modern pathology, 2005-10, Vol.18 (10), p.1295-1304

2005

Volltextzugriff (PDF)

Expression of luminal and basal cytokeratins in human breast carcinoma

The Journal of pathology, 2004-06, Vol.203 (2), p.661-671

2004

Volltextzugriff (PDF)

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation

The Journal of pathology, 2006-03, Vol.208 (4), p.495-506

2006

Volltextzugriff (PDF)

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis

International journal of cancer, 2006-01, Vol.118 (1), p.6-10

2006

Volltextzugriff (PDF)

Early-onset breast cancer - histopathological and prognostic considerations

British journal of cancer, 1997-05, Vol.75 (9), p.1318-1323

1997

Volltextzugriff (PDF)

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

Clinical cancer research, 2006-04, Vol.12 (8), p.2468-2475

2006

Volltextzugriff (PDF)

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis

The American journal of surgical pathology, 2005-06, Vol.29 (6), p.734-746

2005

Volltextzugriff (PDF)

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

British journal of cancer, 2004-10, Vol.91 (8), p.1532-1542

2004

Volltextzugriff (PDF)

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

International journal of cancer, 2005-11, Vol.117 (2), p.248-255

2005

Volltextzugriff (PDF)

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

Modern pathology, 2005-01, Vol.18 (1), p.26-35

2005

Volltextzugriff (PDF)

The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene

Oncogene, 2009-11, Vol.28 (46), p.4041-4052

2009

Volltextzugriff (PDF)

Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer

Endocrine-related cancer, 2005-07, Vol.12 (Supplement_1), p.S99-S111

2005

Volltextzugriff (PDF)

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance

Histopathology, 2005-06, Vol.46 (6), p.685-693

2005

Volltextzugriff (PDF)

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres

The Journal of pathology, 2003-04, Vol.199 (4), p.418-423

2003

Volltextzugriff (PDF)

Expression of the stress‐related MHC class I chain‐related protein MICA is an indicator of good prognosis in colorectal cancer patients

International journal of cancer, 2006-03, Vol.118 (6), p.1445-1452

2006

Volltextzugriff (PDF)

Updated recommendations for HER2 testing in the UK

Journal of clinical pathology, 2004-03, Vol.57 (3), p.233-237

2004

Volltextzugriff (PDF)

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma

European journal of cancer (1990), 2006-02, Vol.42 (3), p.357-362

2006

Volltextzugriff (PDF)

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome

The Journal of pathology, 2004-09, Vol.204 (1), p.93-100

2004

Volltextzugriff (PDF)

An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers

Bioinformatics, 2002-03, Vol.18 (3), p.395-404

2002

Volltextzugriff (PDF)

Phosphorylation of ERK1/2 mitogen‐activated protein kinase is associated with poor response to anti‐hormonal therapy and decreased patient survival in clinical breast cancer

International journal of cancer, 2001-07, Vol.95 (4), p.247-254

2001

Volltextzugriff (PDF)

Abstract P5-08-17: A study of c-Jun N-terminal kinase (JNK) and c-Jun as biomarkers in early breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P5-P5-08-17

2016

Volltextzugriff (PDF)

1 – 25 von 352

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(329)
Mit Volltextzugriff
(313)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(262)
Life Sciences & Biomedicine
(260)
Humans
(246)
Female
(214)
Biological And Medical Sciences
(183)
Medical Sciences
(179)
Breast Neoplasms - Pathology
(143)
Oncology
(138)
Tumors
(132)
Gynecology. Andrology. Obstetrics
(112)
Mammary Gland Diseases
(107)
Prognosis
(105)
Middle Aged
(102)
Pathology
(95)
Aged
(91)
Breast Cancer
(90)
Adult
(86)
Immunohistochemistry
(71)
Investigative Techniques, Diagnostic Techniques
(44)
Breast Neoplasms - Mortality
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

British Journal Of Cancer
(28)
The Journal Of Pathology
(28)
Cancer Research
(21)
Journal Of Clinical Pathology
(20)
Breast
(16)
Breast Cancer Research : Bcr
(16)
Clinical Radiology
(16)
European Journal Of Cancer
(16)
Histopathology
(16)
Breast Cancer Research And Treatment
(13)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

Abstract P3-11-08: Sperm associated antigen 5 (SPAG5) predicts pathological complete response (pCR) and distant relapse risk to HER2 targeting agents and anthracycline based chemotherapy in HER2 positive (HER2+) breast cancer (BC)

Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?

High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

Expression of luminal and basal cytokeratins in human breast carcinoma

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis

Early-onset breast cancer - histopathological and prognostic considerations

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene

Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres

Expression of the stress‐related MHC class I chain‐related protein MICA is an indicator of good prognosis in colorectal cancer patients

Updated recommendations for HER2 testing in the UK

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome

An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers

Phosphorylation of ERK1/2 mitogen‐activated protein kinase is associated with poor response to anti‐hormonal therapy and decreased patient survival in clinical breast cancer

Abstract P5-08-17: A study of c-Jun N-terminal kinase (JNK) and c-Jun as biomarkers in early breast cancer

Suchergebnisse filtern